Hologic (NASDAQ:HOLX) Receives “Outperform” Rating from Raymond James
Raymond James reiterated their outperform rating on shares of Hologic (NASDAQ:HOLX – Free Report) in a research note issued to investors on Friday morning,Benzinga reports. They currently have a $71.00 target price on the medical equipment provider’s stock, down from their prior target price of $90.00. A number of other equities research analysts have also […]
Raymond James reiterated their outperform rating on shares of Hologic (NASDAQ:HOLX – Free Report) in a research note issued to investors on Friday morning,Benzinga reports. They currently have a $71.00 target price on the medical equipment provider’s stock, down from their prior target price of $90.00. A number of other equities research analysts have also […]
